CIP2A and hepatocellular carcinoma: Interestingly, ΔBtz showed significant effects on CIP2A, P-Akt, and P-4EBP1 in a concentration- and time-dependent manner in HCC similar to bortezomib (Fig. 4Bleft & middle).